MedPath

ow dose Prophylaxis study in children with haemaophilia A

Not Applicable
Conditions
Health Condition 1: null- HAEMOPHILIA A
Registration Number
CTRI/2014/03/004494
Lead Sponsor
BAYER AWARD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Severe hemophilia, defined as factor assay showing <1% activity, between 3-7 years of age

2. No single joint should have an HJHS score of more than 5.

3. Not have detectable inhibitors by Bethesda assay ( <0.6 BU) at recruitment

4. Be willing to come for evaluation once in 9-15 months for at least 2 (?4) years. (in case

the study is extended)

Exclusion Criteria

PATIENTS WITH DOCUMENTED INHIBITORS.

NOT WILLING TO COME FOR FOLLOW UP FOR LONG TERM (ATLEAST 4 YEARS)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the feasibility and impact of lower doses of prophylactic clotting factor concentrate (CFC) replacement therapy on the bleeding frequency and musculoskeletal outcome of children with severe hemophilia. <br/ ><br>1.1.2 To correlate this outcome with the dose of CFC used and evaluate if there is a dose-response relationship at these doses.Timepoint: CLINICAL ASSESSMENTS, RADIOLOGICAL ASSESSMENTS, ORTHOPAEDIC ASSESSMENTS WILL BE DONE ONCE IN A YEAR AT YEAR-1,YEAR-2, YEAR-3 AND YEAR-4
Secondary Outcome Measures
NameTimeMethod
1.2.1 To familiarize and promote the use of prophylaxis with CFC for children with hemophilia in developing countries. <br/ ><br>1.2.2 To encourage and standardize the assessment and documentation of musculoskeletal outcome in the participating centers for further dissemination to other centers in the country. <br/ ><br>1.2.3 To create models for prophylactic CFC replacement therapy which are practical in developing countries during their evolution towards optimal hemophilia care.Timepoint: ANNUAL VISIT FOR 4 YEARS
© Copyright 2025. All Rights Reserved by MedPath